B-CELL LYMPHOMA RECURRENT
Clinical trials for B-CELL LYMPHOMA RECURRENT explained in plain language.
Never miss a new study
Get alerted when new B-CELL LYMPHOMA RECURRENT trials appear
Sign up with your email to follow new studies for B-CELL LYMPHOMA RECURRENT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Engineered immune cells take on tough blood cancers in early trial
Disease control OngoingThis early-stage trial tests a new treatment called MB-CART19.1, which uses a patient's own immune cells that are modified in a lab to better find and attack cancer cells. It is for children and adults with certain blood cancers (like leukemia or lymphoma) that have returned or n…
Matched conditions: B-CELL LYMPHOMA RECURRENT
Phase: PHASE1 • Sponsor: Miltenyi Biomedicine GmbH • Aim: Disease control
Last updated May 22, 2026 13:55 UTC
-
New hope for lymphoma patients who Can't have stem cell transplants
Disease control OngoingThis study tests a CAR T-cell therapy called axi-cel as a second treatment for people with aggressive B-cell lymphoma that has come back or not responded to initial therapy, and who cannot have a stem cell transplant. About 62 participants will receive a one-time infusion of thei…
Matched conditions: B-CELL LYMPHOMA RECURRENT
Phase: PHASE2 • Sponsor: The Lymphoma Academic Research Organisation • Aim: Disease control
Last updated May 22, 2026 13:51 UTC